Loading...

Activity of Delafloxacin When Tested Against Bacterial Surveillance Isolates Collected in the US and Europe During 2014–2016 as Part of a Global Surveillance Program

BACKGROUND: Delafloxacin (DLX) is an investigational anionic fluoroquinolone with an NDA that is under US FDA review to treat acute bacterial skin and skin structure infections and is undergoing Phase 3 studies to treat community-acquired bacterial pneumonia. METHODS: A total of 36,683 Gram-positive...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Flamm, Robert K, Shortridge, Dee, Huband, Michael D, McCurdy, Sandra, Pfaller, Michael A
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.918
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!